Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need to Know

On a single day in early January 2019, TrialCard Incorporated’s Pharmacy Fraud Detection team identified and blocked three pharmacies engaged in fraudulent behavior associated with pharmaceutical co-pay programs. These pharmacies submitted claims for payment on expensive prescriptions that were never filled or distributed to patients. Fortunately, TrialCard was able to intercept the fraudulent transactions on the same day they were submitted, thereby saving our client nearly $2 million. Had these claims gone through, the brand’s reimbursement budget for the entire year would have been exhausted. These are not isolated incidents. TrialCard discovers an average of five fraudulent pharmacies per [...]

2019-02-20T14:25:39+00:00February 15th, 2019|

Law and Order: Pharmacy Fraud Unit

I really wanted to begin this blog post with some cheesy line that sounded like the opening monologue of Law and Order (the original, thank you, not one of the 400 spin-offs) but, I will spare you. Fraud is here. It's always been here, to be honest, but now it's taken on an entirely new form. We are not just dealing with what I like to call the "monthly bonus" pharmacy owner who processed one or two fraudulent claims a month. Nope. We have graduated to the big leagues. Now, we see pharmacies open for less than a month, [...]

2019-02-06T14:08:43+00:00February 6th, 2019|

Defining Digital Health

Digital health. It's all the rage. What is it? More importantly, what does it mean to companies like ours that have been building longstanding pharmaceutical partners and successfully interacting with patients, pharmacists, and providers for more than 15 years? TrialCard has invested substantially in attempting to answer this question in two ways. It has attended most, if not all, Digital Health conferences on the East and West coasts. It built QuickPath™, a technology platform that has the ability to scale with future affordability, adherence, and engagement needs of its pharmaceutical partners and their patients. Boldly, I believe TrialCard has an [...]

2018-09-07T14:43:51+00:00September 7th, 2018|

Life as an Intern at TrialCard

When I graduated from college in May, I experienced a mix of emotions. I was proud of myself for everything I had accomplished during my four years at Clemson. I worked in the Social Media Listening Center—a research lab and teaching facility where students could track real-time chatter of events such as presidential elections, sporting events, and other news items. This experience piqued my interest in social media analytics. I also had the opportunity to study abroad in Germany and advance my communication skills and knowledge in public relations. And in my last year of college, I completed my [...]

2018-08-06T10:01:52+00:00July 20th, 2018|

Co-Pay Accumulator Programs

Right now, copay accumulator programs are one of the hottest and most controversial topics being discussed in our industry. This tactic represents a change in prescription drug benefit plan designs offered by pharmacy benefit managers (PBMs) to plan sponsors. Using names such as “out-of-pocket protection” and “coupon adjustment: benefit plan protection,” these programs are designed to shift specialty drug costs to patients and pharmaceutical manufacturer assistance programs, thereby saving plan sponsors money. TrialCard has designed a solution that mitigates the negative impact of this new benefit design. THE PROBLEM In traditional plan designs, copay assistance programs offset costs otherwise [...]

2018-07-20T13:52:55+00:00June 29th, 2018|

Asembia 2018: Hot Topics and Key Industry Trends

Another Asembia is in the rearview mirror and once again I’m amazed at how many key learnings come out of attending this annual trade show. Since last year’s event, there have been numerous industry developments that have dominated the headlines. From the announced mega-mergers of ESI / Cigna and CVS / Aetna to the almost daily chatter about Amazon “disrupting the drug channel” there is a reason for both anxiety and optimism within the specialty drug community. All of these shifting marketplace dynamics created the perfect environment for some collaborative discussions during the course of the conference. Read on to learn about some of the hottest topics and [...]

2018-08-29T11:34:01+00:00May 29th, 2018|

Rare Disease Day 2018: What it Means to a TrialCard Employee

The only thing that’s not rare about rare disease is the energy that the TrialCard team puts behind our 26 customers who manufacture Orphan Drugs and the patients they serve.  At TrialCard, the patient is always our bottom line and that is especially true for patients with rare disease. This year, Rare Disease Day is focused on research.  Research that brings new therapies and new hope to patients with rare disease, half of whom are children.  These patients present with common symptoms that often hide a more proliferative and degenerative disease.  Patients are left with a lower quality of [...]

2018-07-20T13:39:07+00:00February 28th, 2018|

2017: A Year to Be Grateful

In 2017, several of my co-workers experienced significant accomplishments that are worthy of noting.  Many of the accomplishments greatly benefited not only our customers and patients but also our local community. The TrialCard team was recognized for its expansion and creation of jobs in the Triangle, further establishing itself as an industry leader in healthcare, and also surpassing our fundraising goals for multiple charity organizations.Here are some examples of our continuous efforts to bring TrialCard's mission to life:Winning the Triangle Business Journal’s “Corporate Philanthropy Award”Karen Baker being named “Most Inspiring” in the Triangle Business Journal’s “Women in Business” AwardsJoe Abdalla [...]

2018-09-07T12:23:10+00:00December 20th, 2017|